comments
-
OSN Premium
Dissatisfied Patients=Surgeons Sent for Counseling?
by Elizabeth Hofheinz, M.P.H., M.Ed., November 6, 2019 There’s nothing that says, “Power to the People” like the chance to…
Read More » -
Hospitals
MiMedx Comments On FDA Decision Not To Finalize HCT/P Guidance Documents This Year
MARIETTA, Ga., Feb. 3, 2017 /PRNewswire/ — MiMedx Group, Inc. MDXG 2.31%, the leading regenerative medicine company utilizing human amniotic…
Read More » -
Biologics
MiMedx Comments on Flawed Osiris Data Review
MARIETTA, Ga., May 3, 2016 /PRNewswire/ — MiMedx Group, Inc. (NASDAQ: MDXG), the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes…
Read More » -
Recon
Unofficial comments on FDA’s RASD discussion paper
A few weeks ago FDA released a Discussion Paper to facilitate the dialog of the upcoming Public Workshop (starting on Monday). The document is…
Read More » -
And the Winner is…..
James! We wanted to thank all of our commenters as every provided great information that we will try to include…
Read More »